Edawin Injection
Composition : Edaravone 1.5 mg / ml
Read MoreTherapeutic Segment : Nootropics & Neurotonics
Packing : 20 ml bottle in mono carton ampoule
Dosage : 2 times daily with normal saline for 14 days.
Product Information
Edawin Injection contains Edaravone, a neuroprotective agent used to manage conditions involving oxidative stress-related neuronal damage, such as acute ischemic stroke and amyotrophic lateral sclerosis (ALS). It helps reduce free radical-induced neuronal injury, supporting recovery of neurological function and slowing the progression of certain neurodegenerative conditions. The injectable formulation allows rapid delivery of the drug in clinical settings for effective management.
- For neurological recovery following
- Acute Cerebral Ischemia
- Cerebral Infarction
- Oxidative Stress
- Neuronal Apoptosis
- Amyotrophic Lateral Sclerosis (LS)
- Administer the injection intravenously under medical supervision
- Dosage and infusion rate should be as prescribed by the physician
- Monitor neurological status and vitals during administration
- Use only in hospital or clinical settings; do not self-administer.
Edaravone acts as a potent free radical scavenger, neutralizing reactive oxygen species (ROS) that cause oxidative stress and neuronal damage. By reducing oxidative stress, Edaravone helps protect neurons, limit cellular injury, and support neurological recovery.
